Certain medications for chronic inflammatory diseases appear safe during pregnancy

Anti-tumor necrosis factor medications (anti-TNFs) are effective in controlling chronic inflammatory diseases, but some physicians recommend that their patients discontinue them during pregnancy. In an Arthritis & Rheumatology analysis of 528 pregnancies of women exposed to certolizumab pegol (CZP), an anti-TNF approved for treatment of rheumatic diseases and/or Crohn’s disease, 85% of pregnancies resulted in live births, and the rate of major congenital malformations (2%) was similar to those reported for the general population in the United States and Europe.

These findings are reassuring for women of childbearing age affected by chronic inflammatory diseases considering treatment with CZP who wish to become or are pregnant.

Source: Read Full Article